Results 101 to 110 of about 333 (138)

Radiation-Induced Immune Responses from the Tumor Microenvironment to Systemic Immunity. [PDF]

Cancers (Basel)
Png S, Tadepalli S, Graves EE.
europepmc   +1 more source

Characterization of rhesus macaque model for cobalt-60 gamma-radiation source without use of blood product. [PDF]

Sci Rep
Wise SY, Fatanmi OO, Petrus SA, Melendez-Miranda I, Brink M, Packer B, Carpenter AD, Seed TM, Singh VK.   +8 more
europepmc   +1 more source

Significant Reduction of Radiation-Induced Death in Mice Treated with PrC-210 and G-CSF after Irradiation. [PDF]

Radiat Res
Fahl WE, Fahl BL, Schult D, Goesch TR.
europepmc   +1 more source

Widely Used Drugs as Radioprotectors and Radiomitigators

Radiation Diagnostics Radiation Therapy, 2022
The purpose of the review is to briefly list the widely used 43 drugs that can be used as readily available non-toxic radioprotectors and radiomitigators in GDR and relevant situations. Caffeine, acetylcysteine, ceruloplasmin, ibuprofen, acetylsalicylic acid, carnosine, cyclosporine, metformin, cholecalciferol, amifostine, artemisinin ...
I.N. Dykan, A. Alekseyenko, N.N. Kolotilov, I.V. Andrushchenko, S. Anton, E.V. Tuz, A.V. Loboda   +6 more
exaly   +3 more sources

Radioprotectors, Radiomitigators, and Radiosensitizers

, 2023
Abstract This chapter gives an overview of molecules and mechanisms able to intervene with the biological effects of ionizing radiation (IR), either related to their clinical use in radiotherapy or in the field of radiation protection in case of an accidental exposure to radiation and/or nuclear emergencies.
Montoro A., Obrador E., Mistry D., Forte G. I., Bravatà V., Minafra L., Calvaruso M., Cammarata F. P., Falk M., Schettino G., Ahire V., Daems N., Boterberg T., Dainiak N., Chaudhary P., Baatout S., Mishra K. P.   +16 more
exaly   +3 more sources

Radiomitigators: Classification, Pharmacological Properties, and Application Prospects

Biology Bulletin, 2019
A classification of radiomitigators, i.e., antiradiation agents for prevention or reduction of the severity of clinical manifestations of acute radiation syndrome and its delayed and long-term clinical consequences, has been proposed. In the classification proposed, radiomitigators used for prophylaxis and treatment of the immediate and remote clinical
A N Grebenyuk
exaly   +3 more sources

Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts [PDF]

International Journal of Radiation Oncology Biology Physics, 2019
The use of radioprotectors and radiomitigators could improve the therapeutic index of radiation therapy. With the intention of accelerating translation of radiation-effect modulators (radioprotectors and mitigators), the Radiation Research Program and SBIR (Small Business Innovation Research) Development Center within the National Cancer Institute ...
Pataje G S Prasanna, Bhadrasain Vikram, C Coleman   +2 more
exaly   +4 more sources

Potential Ways to Increase Body Resistance to Damaging Action of Ionizing Radiation With Radiomitigators

Biology Bulletin Reviews, 2019
This review considers the potential mechanisms of radiomitigative effect of radioprotective drugs in interaction with pathophysiological processes accompanying radiation injury to tissues at the earliest stages of its development. Radiomitigators affect bodily systems throughout the development of primary radiation stress and inflammatory process upon ...
I B Ushakov, M V Vasin
exaly   +3 more sources